Clinical Trials Browser

Phase 2 × Lymphoma × pasireotide × Clear all

NCT02215070 2021-11-17

Pasireotide in Prevention of GI Toxicity

LymphoidMyeloidOther hematologic neoplasm

Lymphoma, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma